Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 8.92% is 26% above its 5-year average of 7.08%, near the high end of its 5-year range (-20.11%–19.05%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.55% below its 12-month average of 11.23%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
8.92%
NET PROFIT MARGIN AVG TTM
11.23%
NET PROFIT MARGIN AVG 3Y
10.20%
NET PROFIT MARGIN AVG 5Y
7.08%
NET PROFIT MARGIN AVG 10Y
5.65%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-20.55%
CURRENT VS 3Y AVG
-12.50%
CURRENT VS 5Y AVG
+26.01%
CURRENT VS 10Y AVG
+57.84%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.48%
median of 85 covered companies
CURRENT VS SECTOR MEDIAN
-5.86%
vs the sector median at left
Market Cap
$12.38B
Net Profit Margin
-17.77%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
Market Cap
$13.41B
Net Profit Margin
-9.27%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
Market Cap
$11.86B
Net Profit Margin
10.01%
TTM Avg
9.01%
3Y Avg
7.89%
5Y Avg
8.30%
Market Cap
$13.84B
Net Profit Margin
5.57%
TTM Avg
9.62%
3Y Avg
9.77%
5Y Avg
24.94%
Market Cap
$13.89B
Net Profit Margin
35.33%
TTM Avg
28.88%
3Y Avg
23.04%
5Y Avg
19.31%
Market Cap
$11.38B
Net Profit Margin
9.99%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
Market Cap
$11.35B
Net Profit Margin
14.97%
TTM Avg
10.50%
3Y Avg
15.15%
5Y Avg
16.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Penumbra, Inc. (PEN) | $12.64B | 8.92% | 11.23% | 10.20% | 7.08% |
| Tempus AI, Inc. (TEM)vs › | $12.38B | -17.77% | -60.53% | -62.93% | -77.31% |
| Baxter International Inc. (BAX)vs › | $13.41B | -9.27% | -7.30% | -3.29% | 1.14% |
| Encompass Health Corporation (EHC)vs › | $11.86B | 10.01% | 9.01% | 7.89% | 8.30% |
| DaVita Inc. (DVA)vs › | $11.48B | 6.05% | 6.39% | 5.83% | 6.41% |
| The Cooper Companies, Inc. (COO)vs › | $13.84B | 5.57% | 9.62% | 9.77% | 24.94% |
| Exelixis, Inc. (EXEL)vs › | $13.89B | 35.33% | 28.88% | 23.04% | 19.31% |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 9.99% | 10.36% | 10.48% | 22.21% |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 14.97% | 10.50% | 15.15% | 16.71% |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 17.03% | 11.20% | 12.20% | 12.89% |
Operating Margin
12.4%
Net Profit Margin
8.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 8.92% |
| 2026-03-31 | 8.69% |
| 2025-12-31 | 12.28% |
| 2025-09-30 | 12.93% |
| 2025-06-30 | 13.34% |
| 2025-03-31 | 12.10% |
| 2024-12-31 | 10.68% |
| 2024-09-30 | 9.81% |
| 2024-06-30 | -20.11% |
| 2024-03-31 | 3.95% |
| 2023-12-31 | 19.05% |
| 2023-09-30 | 3.40% |
| 2023-06-30 | 7.25% |
| 2023-03-31 | 3.55% |
| 2022-12-31 | 1.75% |
| 2022-09-30 | -1.06% |
| 2022-06-30 | -1.77% |
| 2022-03-31 | 0.04% |
| 2021-12-31 | -12.07% |
| 2021-09-30 | 4.66% |
| 2021-06-30 | 5.01% |
| 2021-03-31 | 7.00% |
| 2020-12-31 | 2.19% |
| 2020-09-30 | -5.83% |
| 2020-06-30 | -11.38% |
| 2020-03-31 | 1.04% |
| 2019-12-31 | 6.67% |
| 2019-09-30 | 8.23% |
| 2019-06-30 | 12.36% |
| 2019-03-31 | 8.33% |
| 2018-12-31 | 5.51% |
| 2018-09-30 | -16.93% |
| 2018-06-30 | 12.20% |
| 2018-03-31 | 5.35% |
| 2017-12-31 | 9.46% |
| 2017-09-30 | 0.28% |
| 2017-06-30 | -1.93% |
| 2017-03-31 | -4.24% |
| 2016-12-31 | 20.46% |
| 2016-09-30 | 17.72% |
| 2016-06-30 | 4.63% |
| 2016-03-31 | 3.96% |
| 2015-12-31 | 3.00% |
| 2015-09-30 | 1.79% |
| 2015-06-30 | -6.31% |
| 2015-03-31 | 6.42% |
| 2014-12-31 | 1.18% |
| 2014-09-30 | 0.53% |
| 2014-06-30 | 0.24% |
| 2014-03-31 | 1.07% |
